The Hyderabad-based Granules India Ltd (GIL), manufacturer of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, has entered into agreements with three European companies for the export of tablets, it is learnt.
According to the company, it has entered into agreements with three European companies to export tablets. As per the agreement, Granules will manufacture tablets for the European firms and they would be marketing it under their brand name. Sources said that it would be more of like contract manufacturing business. It has recently received approval from the European regulatory authorities for its new six billion tablet facility located at Gagillapur in Andhra Pradesh. It is also in discussions with two more European firms for the export of tablets to the region, it is learnt.
The details can be read here.
No comments:
Post a Comment